A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

• Status: Terminated
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a safety and efficacy study of a Dexamethasone Drug Delivery System for anterior segment inflammation and pain following cataract extraction with lens implantation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate

Criteria

Inclusion Criteria:

• Planned single cataract extraction with lens implant

• Best-corrected visual acuity of 20/200 or better in the opposite eye

Exclusion Criteria:

• Glaucoma or history of intraocular hypertension in the study eye

• History of chronic ocular allergy in the last year requiring treatment

• Scheduled for cataract surgery in the non-study eye during study participation